Default company panoramic image
A7784f33 f163 4db4 9811 195d68d13fea

Axerion Therapeutics

We are developing therapeutics for the management and treatment of Alzheimer's Disease and Chronic Spinal Cord Injury with IP licensed from Yale.,

  • Stage Concept Only
  • Industry Biotechnology
  • Location New Haven, CT, USA
  • Currency USD
  • Employees 7
  • Website axeriontherapeutics.com

Company Summary

Team

  • Default avatar
    Sylvia McBrinn
    President and CEO

  • Default avatar
    Sean Cassidy
    V P and CFO

  • Default avatar
    George Maynard
    VP Medicinal Chemistry

  • Default avatar
    Eric Frieden
    VP Process Science

Advisors

  • Default avatar
    Sills Cummis
    Lawyer
    Unconfirmed
    Default avatar
    PriceWaterhouseCoopers
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Connecticut Innovations
    Unconfirmed